
Jason Besecker, OD, MS, is the founder of EnVision Dry Eye Center, a specialty eye-care clinic in Nampa, Idaho, devoted exclusively to the evaluation, treatment and long-term management of dry eye disease and ocular surface conditions.
Dr. Besecker uses detailed clinical examination and objective diagnostic testing to identify the factors contributing to each patient’s symptoms. He then develops an individualized treatment plan directed at those underlying causes.
Patients visit EnVision Dry Eye Center from Boise, Nampa, Meridian, Caldwell and communities throughout the Treasure Valley, as well as from across Idaho and surrounding states.
Dry eye is a complex, multifactorial condition. Two patients may experience similar burning, watering or fluctuating vision while having very different underlying causes.
Dr. Besecker’s approach is to determine what is disrupting the tear film and ocular surface for each patient. Potential contributors may include meibomian gland dysfunction, aqueous tear deficiency, eyelid disease, inflammation, infection, allergies, hormonal changes, systemic disease, medication use, contact lens wear, previous eye surgery or corneal damage.
Rather than relying on a one-size-fits-all treatment sequence, Dr. Besecker uses the patient’s symptoms, history, diagnostic results and examination findings to develop a personalized plan. Treatment may address several contributing factors simultaneously and may be adjusted over time according to the patient’s response.
While working at Hollingshead Eye Center, a cataract and LASIK referral center, Dr. Besecker saw how frequently dry eye affected patients’ comfort, vision and surgical outcomes.
Beginning around 2018, meaningful advances were emerging in dry-eye diagnostics and treatment. These developments created new possibilities for identifying the causes of dry eye and treating patients whose symptoms had not improved with traditional approaches. However, many of these services were not readily available in the Treasure Valley.
Dr. Besecker founded EnVision Dry Eye Center in 2021 to provide his community with dedicated access to comprehensive dry-eye diagnostics, personalized treatment planning and advanced ocular-surface procedures.
Dr. Besecker evaluates and manages a broad range of dry-eye and ocular-surface conditions, including:
Meibomian gland dysfunction
Evaporative dry eye
Aqueous-deficient dry eye
Keratoconjunctivitis sicca
Anterior blepharitis
Demodex blepharitis
Ocular rosacea
Allergic conjunctivitis
Neurotrophic keratitis
Recurrent corneal erosions
Contact lens-related dry eye
Post-refractive-surgery dry eye
Epiphora, or excessive tearing
Dry eye associated with Sjögren’s disease
Dry eye associated with rheumatoid arthritis, lupus and other autoimmune diseases
Dry eye associated with diabetes
Menopause- and hormone-associated dry eye
Some systemic conditions require coordinated care with the patient’s primary-care physician, rheumatologist, endocrinologist or another medical specialist. EnVision’s role is to evaluate and manage their effects on the tear film and ocular surface.
A comprehensive evaluation helps Dr. Besecker determine whether a patient meets the diagnostic criteria for dry eye and identify the factors driving the condition.
Diagnostic testing may include:
Meibography: Images the structure of the meibomian glands and identifies gland changes or loss.
Noninvasive tear breakup time: Measures how long the tear film remains stable between blinks without using fluorescein dye.
Tear osmolarity: Evaluates tear-film concentration and loss of ocular-surface homeostasis.
Fluorescein staining: Helps identify tear-film instability and areas of corneal or conjunctival damage.
High-resolution slit-lamp imaging: Documents the eyelids, tear film and ocular surface in detail and allows findings to be monitored over time.
These findings are interpreted alongside the patient’s symptoms, medical history, medications, lifestyle, previous treatments and clinical examination. Testing is used to guide treatment not simply to assign every patient the same dry-eye diagnosis.
Depending on the diagnosis and clinical findings, treatment options at EnVision Dry Eye Center may include:
Meibomian Gland and Eyelid Treatments
Intense Pulsed Light therapy
Tixel thermomechanical treatment
TearCare
Red-light therapy
BlephEx
Rinsada
NuLids
Platelet-rich plasma tears
Autologous serum tears
Punctal plugs
LacriFill canalicular filler
Amniotic tissue contact lenses, including PROKERA
Plasma pen conjunctivoplasty
Superficial keratectomy
Anterior stromal micropuncture using Plexitome
Not every treatment is appropriate for every patient. Recommendations are based on the suspected causes of the condition, disease severity, ocular-surface findings, previous treatment response, medical history and individual treatment goals.
Dr. Besecker earned both a Bachelor of Science and Master of Science in Biology from Boise State University before completing his Doctor of Optometry degree at Indiana University School of Optometry.
His clinical training included experience in ocular disease management, primary eye care and pre- and postoperative surgical care at:
From 2014 through 2021, Dr. Besecker practiced at Hollingshead Eye Center, where he gained extensive experience in ocular disease and surgical co-management before opening EnVision Dry Eye Center.
He has also completed procedure- and technology-specific training in IPL, Tixel, plasma pen, BlephEx and Rinsada.
Dr. Besecker is a member of the Tear Film & Ocular Surface Society and Ophthalmic World Leaders.
He has presented on dry eye and ocular surface disease to eye-care professionals across the country. He serves as a speaker and consultant for Bausch + Lomb and BioTissue and as a consultant for Tarsus Pharmaceuticals.
His clinical and professional articles have appeared in Optometric Management, Modern Optometry and Review of Optometry. Selected publications include:
“Rethinking the Dry Eye Disease Stepladder: Applying TFOS DEWS III to Clinical Practice”, Optometric Management, July–August 2026
“The Importance of Increasing OD-to-OD Referrals”, Modern Optometry, April 2024
“An Unnerving Situation”, Review of Optometry, February 2023
Dr. Besecker has also discussed dry-eye care, collaborative care and specialty-practice development on professional podcasts, including:
“Running a Standalone Dry Eye Clinic”, To the Point
“Flipping the Model—Creating a Medical Dry Eye Center”, Clique on Dry Eye
“The Power of Comanaging With Jason Besecker”, The OI Show, Optometric Insights Media
“In Consideration of House Calls and OD-to-OD Referrals”, The MOD Pod, Modern Optometry
These educational activities allow Dr. Besecker to share clinical experience with other eye-care professionals while remaining engaged with developments in dry-eye and ocular-surface care.
Dr. Besecker believes patients deserve to understand what is contributing to their symptoms, why a particular treatment is being recommended and what the treatment is intended to accomplish.
His goal is to listen carefully, provide understandable information and develop a treatment plan that reflects each patient’s diagnosis, priorities and daily challenges. Because dry eye is frequently chronic and multifactorial, he emphasizes ongoing education, consistent follow-up and thoughtful adjustment of the treatment plan over time.
Consider scheduling an evaluation if you experience persistent burning, grittiness, redness, excessive tearing, fluctuating vision, light sensitivity, contact lens intolerance or eye discomfort that has not improved with standard treatment.
EnVision Dry Eye Center
3752 E Amity Avenue, Suite 103
Nampa, Idaho 83687
Get Directions
(208) 490-8823